 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| RXMD Takes Another Giant Step with Development of Proprietary Tele-pharmacy Software |
|
 Hot Stock to Watch |
Company: Progressive Care Inc. (OTCQB: RXMD)
|
Last:
Price: 0.0815
Change (%): - 0.0015 (1.81)
Volume: 1,243,146 |
 |
Progressive Care Begins Development of Proprietary Tele-pharmacy Software for Exclusive Use
Leading Florida-Based Healthcare Services and Technology Company Expands its Kiosk Program in Florida
MIAMI, May 24, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company has started the development of its own proprietary tele-pharmacy software in order to digitally communicate with patients, physicians, pharmacists and caretakers across the world.
The move comes as part of Progressive Care’s overall effort to expand its current kiosk program throughout the state of Florida. The company has hired six new software coders to work alongside Mass Ventures Corporation and deliver a state of the art multi-platform technology capable of running on kiosk, desktop, and mobile devices. In addition to developing its own proprietary software, the new team will also be updating the website of the company wholly owned subsidiary, PharmCo, LLC.
“Our success with prescription management has allowed us to begin developing our own proprietary tele-pharmacy software. After configuring a third-party platform in our kiosks, we realized the need to develop a more customized solution for our customers,” said S. Parikh Mars, CEO of Progressive Care Inc. “We believe that with the completion of this new software, along with Progressive Care’s current contingent of pharma-robotic equipment, we will be that much closer to becoming the leader in personalized healthcare services and technology.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
